null (not a single molecule; refers to a group) (null)

Platelet surface proteins are a large and diverse group of membrane proteins expressed on the surface of platelets. These proteins mediate key processes in hemostasis, thrombosis, immune response, and vascular biology. The most therapeutically relevant platelet surface proteins include receptors such as P2Y12, integrin αIIbβ3 (glycoprotein IIb/IIIa), and PAR-1, which are central to platelet activation and aggregation. Other surface proteins like P-selectin are important in platelet-leukocyte interactions and in the pathology of inflammation and cancer metastasis. Drugs targeting these proteins are widely used for the prevention and treatment of thrombotic disorders, though their use can be associated with significant bleeding risks. "Platelet surface proteins" as a label is non-specific and should be replaced by precise protein targets in scientific or therapeutic contexts.

Other names

platelet membrane proteinsplatelet surface antigensplatelet adhesion molecules

Inhibition of platelet activation pathways (e.g., P2Y12 signaling); Blockade of integrin-mediated aggregation (αIIbβ3 antagonism); Inhibition of platelet adhesion and migration; Blockade of thrombin receptor (PAR-1) activation